Background: In 2003, the International Pharmaceutical Federation (FIP) adopted a policy stating pharmacists have an important role to play in tobacco control. In 2005, the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) developed the Global Health Professions Student Survey (GHPSS) to collect information on student tobacco use and training received on patient cessation counseling while in school. This study includes data from GHPSS conducted among 3 rd year pharmacy students in 44 countries and the Gaza Strip/West Bank. Methods: A two-stage sample design was used to select schools and students for participation in the GHPSS. Self-administered data collection followed for 3 rd year students in selected schools and classes. Results: Twenty-eight of the 40 sites with data for males reported rates greater than 20%; with only 4 sites reporting rates less than 5%. Thirteen of the 44 sites with data for females reported rates greater than 20%; with 21 sites reporting rates less than 5%. The majority of students recognized that they are role models in society, believed they should receive training on counseling patients to quit using tobacco, but few reported receiving formal training. Conclusions: Following FIP recommendations, pharmaceutical organizations must discourage tobacco use among pharmacists and universities teaching pharmacy must implement programs that train pharmacists in effective patient tobacco cessation-counseling techniques.
INTRODUCTION
In 2003, the International Pharmaceutical Federation (FIP) adopted the following policy, "Statement of Policy on the Role of the Pharmacist in Promoting a Tobacco Free Future." [1] The FIP position states, "Pharmacists, in common with all other health professionals, have a responsibility to help people to give up smoking or other forms of tobacco use as well as to encourage the rest of the population to do so." 1 The FIP noted that, "Studies have shown that brief counseling by health professionals on the dangers of smoking and the minor importance of quitting is one of the most cost-effective methods to reduce tobacco use."
[1] The FIP policy statement [1] lists a number of recommendations, including:
• Pharmaceutical organizations should provide both basic and continuing education to pharmacists, pharmacy students and pharmacy assistants on tobacco use, quitting processes, and associated health risks.
• Pharmaceutical organizations should participate in the Tobacco Free Initiative of the World Health Organization through the FIP pharmaceutical and regional forums.
• Individual pharmacists should provide an example and leadership by being free of tobacco themselves.
In 2005, the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) developed the Global Health Professions Student Survey (GHPSS) to collect information on student tobacco use and training they had received while in school on patient cessation counseling. [2] The data reported in this study extends the information reported in 2005 by including data reported by 3 rd year pharmacy students in 44 countries (Iraq has completed the survey in two regions, Kurdistan and Baghdad) and the Gaza Strip/West Bank (the 46 will be identified as "sites" for the remainder of this paper). This study includes data on tobacco use and training to provide patient cessation counseling among 3 rd year pharmacy students. Table 1 lists the 46 sites that completed the Pharmacy GHPSS by year, WHO Region, and country.
METHODS

Design
The Pharmacy GHPSS is part of the Global Tobacco Surveillance System, which collects data through four surveys: the Global Youth Tobacco Survey, the Global School Personnel Survey, the Global Adult Tobacco Survey, and the GHPSS. [3] The GHPSS is a schoolbased survey of 3rd year students pursuing advanced degrees in dentistry, medicine, nursing and pharmacy. GHPSS includes 3 rd year students because in most countries these students are advanced in their training; yet not in clinical settings. The GHPSS uses a twostage sample design and follows one of two options:
1. If the number of schools teaching 3 rd year pharmacy students is less than 15 the study includes ALL schools. If the number of 3 rd year students is greater than 2000 then a random sample of classes teaching 3 rd year students is made and students in those classes participate in the survey; otherwise, all students are included in the study.
If the number of schools teaching 3
rd year pharmacy students is greater than 15 then a sample of schools is made (selection of schools is probability proportional to school enrollment size). If the number of 3 rd year students is greater than 2000 then a random sample of classes teaching 3 rd year students is made and students in those classes participate in the survey; otherwise, all students are included in the study.
The Pharmacy GHPSS included a census of schools and students in all locations, except in Bangladesh (17 schools), India (216 schools), and the Philippines (19 schools), where a sample of schools was selected with probability proportional to size from all pharmacy schools in the country and a census of students in the selected schools were surveyed ( Table 2 ).
The Pharmacy GHPSS was conducted in schools during regular lectures and class sessions. Anonymous, self-administered data collection procedures were followed. The questionnaire included the following topics: demographics, prevalence of cigarette smoking and use of other tobacco products (other products vary from region to region and include smokeless tobacco, bidis, water pipe, and forms of other tobacco products unique to individual countries), exposure to secondhand smoke, desire to quit smoking, and training received to provide patient counseling on cessation techniques. Where appropriate, the final country questionnaires were translated into local languages and back-translated to check for accuracy. SUDAAN, a software package for statistical analysis of survey data, was used to calculate weighted prevalence estimates and standard errors (SE) of the estimates (95% confidence intervals (CI) were calculated from the SEs). [4] For all sites, excluding Bangladesh, India, and the Philippines, a finite population correction factor was applied to take into account non-response and used in the variance of the estimates. T-tests were used to determine differences between subpopulations. [5] [6] In this paper, differences in proportions were considered statistically significant if the t-test p-value was less than 0.05.
For sites conducting the Pharmacy GHPSS, the school response rate was 100% in 43 of the 46 sites (lowest was 80.0% in Russian Federation); the class response rate was 100% in all sites; the student response rate ranged from 54.5% (Greece) to 100% (Czech Republic, Russian Federation, Slovakia, and Mongolia); and the overall response rate ranged from 54.5% (Greece) to 100% (Czech Republic, Slovakia, and Mongolia) ( Table 1 ). The number of students who participated in each survey varied due to the number of schools and student enrollment for each country in each sample design.
Measurement
This report includes information on current cigarette smoking, current use of tobacco products other than cigarettes (including smokeless tobacco, bidis, water pipe, and forms of other tobacco products unique to individual countries). In addition, attitude questions were asked regarding: pharmacy health professionals as role models for their patients, whether health professionals think they should get training in patient cessation techniques, and if they have ever received formal training on such cessation counseling techniques.
Results in this report are presented by WHO region with participating countries identified. The six WHO regions are the African Region, the Eastern Mediterranean Region, the European Region, the Region of the Americas, the South-East Asian Region, and the Western Pacific Region.
RESULTS
Student Characteristics
The percentage of pharmacy students who were females was over 60% in all sites except Ghana, Kenya, Senegal, Zambia, Iran, Yemen, Chile, Peru, Bangladesh, India, Lao's PDR, and Papua New Guinea. Over 80% of the students were females in seven sites (Bosnia & Herzegovina, Czech Republic, Russian Federation, Bolivia, Guyana, Myanmar, and Mongolia) . Over 90% of the students were less than 25 years old in every site in the Eastern Mediterranean, European, South-East Asian, and Western Pacific (except Lao's PDR, Mongolia, and Papua New Guinea) regions. In the African region, the percent age 25-29 ranged from 0.0% in Kenya (all were age 24 or younger) to 53.4% in Zambia. In Zambia 19.2% of the students were ages 30 or older. In the Americas, the majority of students were under age 25; the percent aged 25-29 ranged from 23.3% (Brazil) to 7.8% (Chile). In Brazil and Trinidad & Tobago, 24% of the students were 30 or older.
Tobacco Use
Among 3 rd year pharmacy students, eight sites had current cigarette smoking rates equal to or above 30% (Albania, Republic of Moldova, Russian Federation, Slovakia, Chile, Guatemala, Papua New Guinea and Peru) and eight sites had rates less than 5% (Ghana, Senegal, Zambia, Guyana, Jamaica, Myanmar, Lao's PDR, and Thailand) ( Table 2 ). Twenty-eight of the 40 sites with data for males reported rates greater than 20%; with only 4 sites reporting rates less than 5%. Thirteen of the 44 sites with data for females reported rates greater than 20%; with 21 sites reporting rates less than 5%. In the African region, males were more likely to smoke cigarettes than females in four of five sites; in the Eastern Mediterranean region, males were more likely than females to smoke cigarettes in all eight sites; in the European region, males were more likely to smoke than females in four of 11 sites, females were more likely than males to smoke in five of 11 sites, and there was no difference in Moldova and Greece; in the Americas, there was no gender difference in five of the seven sites (males had higher rates than females in Bolivia and Peru); in the South-East Asia region, males had higher rates than females in all four sites reporting data; and in the Western Pacific region, females were more likely to smoke than males in Lao's PDR while males had higher rates than females in Cambodia, Fiji, Mongolia, and the Philippines.
Among pharmacy students, current use of other tobacco products was 0% in eight sites (Ghana, Kenya, Senegal, Belize, Guyana, Jamaica, Trinidad & Tobago, and Cambodia); less than 5% in 23 sites; and over 15% in Gaza Strip/West Bank, Iraq (Baghdad), Lebanon, Syria, Greece, Latvia, Guatemala, Bangladesh, Fiji, and Papua New Guinea ( Table 2) . Nine of the 40 sites with data for males reported rates greater than 20%; with 16 sites reporting rates less than 5%. One (Lebanon) of the 44 sites with data for females reported rates greater than 20%; with 27 sites reporting rates less than 5%.In the African region, males were more likely to use other products than females in Algeria while females were more likely than males in Zambia; in the Eastern Mediterranean region, males were more likely than females to use other products in seven of eight sites (no difference in Lebanon); in the European region, males were more likely to use other products than females in four of 11 sites, females were more likely than males to use other products in four of 11 sites, and there was no difference in Bosnia & Herzegovina, Czech Republic, and the Republic of Moldova; in the Americas, there was no gender difference in four of the eight sites reporting data, males had higher rates than females in Bolivia, Chile, and Peru, females had higher rates than males in Uruguay; in the South-East Asia region, males had higher rates than females in Thailand and Myanmar(there was no gender difference in Bangladesh or India); and in the Western Pacific region, males had higher rates than females in Fiji, Mongolia and Lao's PDR; there was no gender difference in the Philippines or Cambodia.
Health Professional Roles and Training
Over 80% of the students thought pharmacist have a role in giving advice about smoking cessation to patients in 39 of 46 sites, with 25 over 90% (including four of five sites Africa and five of six sites in the Western Pacific) ( Table 3 ). The lowest was in Slovakia (58.4%) and Brazil (57.7%). Over 90% of the students thought health professionals should get specific training on cessation techniques in 34 of the 46 sites, with Latvia, Belize, Panama, Cambodia, and Papua New Guinea at 100%. The lowest was in the European region with seven of 11 below 90%. Less than 40% of the students reported having ever received some kind of formal training in their professional school on cessation approaches to use with their patients in 41 of the 46 sites; less than 20% in 28 sites, and less than 10% in 12 sites. Over 40% of the students had received formal training in Algeria (41.8%), Armenia (40.5%), Latvia (82.5%), Fiji (80.0%), and Jamaica (40.0%). 8 -51.4) 65. 8 (58.0 -72.9) 38. 9 (34.1 -44.0) 0.0000 1.9 (1.1 -3.3) 0.0 2.6 (1. 5 -4.4) 0.0004 2006 17.1 (14.0 -20.8) 56.0 (47. 4 -64.3) 1. 3 (0.5 -3.2) 0.0000 2.8 (1. 7 -4.6) 6.7 (3.6 -12.2) 1. 3 (0.5 -3.1) 0.0121 Bosnia & Herzegovina 2006 29.4 (28.2 -30.7) 25.0 (21. 9 -28.5) 30.1 (28. 7 -31.4) 0.0062 5.5 (4.9 -6.2) 4.2 (2.9 -6.1) 5.7 (5.0 -6.4) 0.0913
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NA -Not available One of the recommendations stated "Individual pharmacists should provide an example and leadership by being free of tobacco themselves." [1] Findings from the Pharmacy GHPSS are not encouraging. Twenty-eight of the 40 sites with data for males and 13 of the 44 sites with data for females report current cigarette smoking rates greater than 20%. The FIP statement that pharmacists should "be free of tobacco themselves" [1] was not found in any of the 40 sites with data for males; and was found for only 6 of the 44 sites for females.
Results from this study suggest that pharmacy schools need to consider including a twopronged tobacco cessation approach for their students: 1) Information about the harmful effects of tobacco use to encourage students not to smoke, or for those who smoke to quit; and 2) Cessation information to provide assistance to students who are motivated to quit.
Cessation Counseling
The 2003 FIP policy statement recommended, "Pharmaceutical organizations should provide both basic and continuing education to pharmacists, pharmacy students, and pharmacy assistants on tobacco use, quitting processes, and associated health risks". The Clinical Practice Guidelines [7] recommends health professionals follow the 5 A's (Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, and Arrange follow-up) for those patients who want to quit using tobacco and the 5 R's (Relevance, Risks, Rewards, Roadblocks, and Repetition) for those patients who do not want to quit. Results from the Pharmacy GHPSS show that over 80% of pharmacy students recognize that they are role models in society (in 40 of 45 sites), over 90% think they should receive training on counseling and treating patients to quit using tobacco (36 of 45 sites), but less than 40% have received formal training in 42 of 46 sites. Results from this study suggest the FIP needs to work closely with member universities and pharmaceutical organizations to assist in developing both basic and continuing education programs aimed at teaching effective patient cessation counseling techniques. Basic and continuing education curricula could include independent courses or additions to existing courses specifically relevant to tobacco cessation.
Limitations
Little information about the process of teaching pharmacy students in low and middle-income countries about smoking prevention and cessation is accessible to the international tobacco control community. Peerreviewed studies in international settings about educational materials and techniques to improve the capacity of pharmacists to counsel patients on cessation are necessary to focus limited resources on effective and efficient strategies to reduce the prevalence of tobacco use. Efforts should be made to assess and share the content of tobacco control components within the formal training curricula and continuing education courses for pharmacy students. Further research should be carried out to assess the impact of existing tobacco control-related materials and training provided in pharmacy schools in a variety of cultural and economic environments.
In particular, the Pharmacy GHPSS is subject to at least three limitations. First, as this study is representative of 3 rd year students who have not had extensive interaction with patients, these survey results should not be extrapolated to practicing pharmacists. Second, data were based on the self-report of students, who might underreport or over-report their behaviors or attitudes. The extent of this bias cannot be determined from these data; however, reliability studies in the United States have indicated good test-retest results for similar tobacco-related questions. [8] In addition, a reliability study of the GHPSS questionnaire was conducted in the United States in 2005; but not internationally. [9] Lastly, the sites including in this study are not representative of individual WHO regions given the number of sites included per region (of the 193 WHO Member States we report data for 44 countries and the Gaza Strip/West Bank).
CONCLUSIONS
Tobacco use is a serious health problem, WHO estimates over 5 million deaths a year can be attributed to tobacco. [10] If current trends continue, WHO estimates tobacco attributable mortality will exceed 8 million per year by 2030. A disproportionate share of the global tobacco burden falls on developing countries, where 84% of current smokers reside. Health professionals, including pharmacist, have important roles to play in tobacco control. Pharmacist who use tobacco can be role models by stopping and all pharmacist can provide patient counseling on tobacco use prevention and cessation. Educational institutions, public health organizations, and education officials should follow the lead of the FIP and discourage tobacco use among pharmacists. These groups should also work together to design and implement programs that train pharmacy students on effective cessationcounseling and treatment techniques. Concurrently, additional research is needed to improve the evidence base for effective tobacco-related curricula, especially materials that are appropriate for a range of cultural and economic settings.
• Over 80% of pharmacy students recognize that they are role models in society
• Over 90% of pharmacy students think they should receive training on counseling and treating patients to quit using tobacco Less than 40% of students have received formal training on patient counseling techniques.
